– UK, Nether Alderley – TheraCryf plc (LON: TCF), a clinical-stage drug development company focused on neuropsychiatry and oncology, announced the appointment of Ed Wardle to its Board as a Non-Executive Director, with immediate effect, nominated by the largest shareholder, Tracarta Ltd.…
– USA, TX – Plus Therapeutics, Inc. (Nasdaq: PSTV), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, announced the appointment of Kyle Guse to its Board of Directors.…
– IRELAND, Dublin – Amarin Corporation plc (NASDAQ: AMRN) announced the appointment of Michael Torok to its Board of Directors, effective immediately.…
– UK, Guildford – Futura Medical plc (LON: FUM), the consumer healthcare company behind Eroxon, that specialises in the development and global commercialisation of innovative and clinically proven sexual health products, announced the appointment of Harmesh Suniara to its Board as a Non-executive Director, with immediate effect
About Harmesh Suniara
Harmesh Suniara has over 17 years’ experience of working in investment management, with a particular focus on UK small and mid-cap equities.…
– USA, CA – Contineum Therapeutics, Inc. (NASDAQ: CTNM), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation, and immunology indications, announced the appointment of Dr.…